Friday, June 11, 2021 3:14:54 PM
Fat ass Hal has gotten taken to cleaners on quality small cap bios that have got explosive growth in their DNA like HEPA.
HEPA the signals couldn’t be clearer this has 10x written all over it.
HEPA Setting up for a move!
HEPA BUY AND HODL Diamond Hands Laser eyes.
Nash Phase 2 & 3 Trials by companies in the space:
AKRO Akero Therapeutics 1.1 Billion Marketcap 240 Million in cash
MDGL Madrigal Pharmaceutical 1.7 Billion Marketcap 300 Million n cash
HEPA Hepion Pharmaceuticals 170 Million market cap 120 million n cash
$HEPA
HEPA the signals couldn’t be clearer this has 10x written all over it.
HEPA Setting up for a move!
HEPA BUY AND HODL Diamond Hands Laser eyes.
Nash Phase 2 & 3 Trials by companies in the space:
AKRO Akero Therapeutics 1.1 Billion Marketcap 240 Million in cash
MDGL Madrigal Pharmaceutical 1.7 Billion Marketcap 300 Million n cash
HEPA Hepion Pharmaceuticals 170 Million market cap 120 million n cash
$HEPA
Recent HEPA News
- Hepion Pharmaceuticals In-Licenses ctRNA Biomarker Assay to Facilitate Early Diagnosis and Surveillance of Hepatocellular Carcinoma • GlobeNewswire Inc. • 03/03/2026 12:35:00 PM
- Hepion Pharmaceuticals Successfully Completes Application to the OTCQB • GlobeNewswire Inc. • 06/25/2025 12:30:00 PM
- Hepion Pharmaceuticals Announces Dr. Kaouthar Lbiati as Interim Chief Executive Officer • GlobeNewswire Inc. • 06/16/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2025 09:00:12 PM
- Hepion Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq • GlobeNewswire Inc. • 05/12/2025 08:30:00 PM
- Hepion Pharmaceuticals Executes Binding Letter of Intent with New Day Diagnostics to Commercialize Diagnostic Tests for Celiac Disease, Respiratory Multiplex, H. Pylori and HCC • GlobeNewswire Inc. • 05/07/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2025 12:59:37 PM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 04/23/2025 08:05:48 PM
